RAPP Earnings Rapport Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–12 of 12
| Q1 2026 | 2026-03-31 | -0.42 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -2.86 | 2026-03-10 | 10-K |
| Q3 2025 | 2025-09-30 | -2.15 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -1.44 | 2025-08-07 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.68 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -3.78 | 2026-03-10 | 10-K |
| Q3 2025 | 2024-09-30 | -3.66 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -6.42 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -11.07 | 2025-05-08 | 10-Q |
| FY 2024 | 2023-12-31 | -23.10 | 2025-03-11 | 10-K |
| Q3 2024 | 2023-09-30 | -14.72 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -8.96 | 2024-08-08 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.